Stock listing
gettex:69C Tvardi Therapeutics, Inc. Aktie
German listing (gettex) of Tvardi Therapeutics, Inc. · home listing NASDAQ:TVRD
Follow Tvardi Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:TVRD
$0.793 USD -0.070 (-8.1%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:TVRD
- Day range
- $0.775 – $0.928 USDOct 30, 2026
- Volume
- 154,830 sharesOct 30, 2026
- Market cap
- $10.58M USDAt the close on Oct 30, 2026 · price × 13.34M shares outstanding
- 52-week range
- $0.775 – $5.690 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $285,186 USDMedian day 137,915 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:TVRD · Home | $0.793 USD | -0.070 (-8.1%) | 154,830 | $0.868 | $0.928 | $0.775 | $0.863 | Close on Oct 30, 2026 |
| Frankfurt:69C | €0.67 EUR | 0.00 (0.0%) | — | €0.63 | €0.67 | €0.63 | €0.67 | Close on Oct 27, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:TVRD · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.793 | -0.070 | -8.1% | $0.868 | $0.928 | $0.775 | 154,830 | |
| $0.863 | -0.024 | -2.7% | $0.890 | $0.915 | $0.850 | 111,486 | |
| $0.887 | +0.022 | +2.5% | $0.860 | $0.927 | $0.859 | 86,047 | |
| $0.865 | +0.023 | +2.8% | $0.831 | $0.900 | $0.831 | 72,687 | |
| $0.842 | -0.098 | -10.4% | $0.940 | $0.970 | $0.842 | 139,029 | |
| $0.940 | -0.032 | -3.3% | $1.070 | $1.070 | $0.920 | 108,300 | |
| $0.972 | -0.048 | -4.7% | $1.010 | $1.050 | $0.972 | 55,400 | |
| $1.020 | +0.028 | +2.8% | $1.020 | $1.090 | $1.000 | 136,800 | |
| $0.992 | +0.022 | +2.3% | $1.030 | $1.076 | $0.970 | 195,200 | |
| $0.970 | -0.040 | -4.0% | $1.010 | $1.028 | $0.969 | 201,300 | |
| $1.010 | -0.060 | -5.6% | $1.050 | $1.069 | $1.000 | 91,800 | |
| $1.070 | +0.070 | +7.0% | $1.030 | $1.070 | $1.000 | 94,000 | |
| $1.000 | -0.040 | -3.8% | $1.010 | $1.030 | $0.990 | 75,700 | |
| $1.040 | -0.020 | -1.9% | $1.060 | $1.060 | $1.012 | 73,400 | |
| $1.060 | +0.030 | +2.9% | $1.020 | $1.080 | $0.970 | 248,100 | |
| $1.030 | -0.050 | -4.6% | $1.090 | $1.090 | $1.020 | 130,300 | |
| $1.080 | -0.020 | -1.8% | $1.100 | $1.100 | $1.040 | 159,900 | |
| $1.100 | +0.020 | +1.9% | $1.080 | $1.110 | $1.040 | 136,500 | |
| $1.080 | -0.060 | -5.3% | $1.150 | $1.180 | $1.070 | 148,300 | |
| $1.140 | -0.010 | -0.9% | $1.170 | $1.170 | $1.120 | 148,300 | |
| $1.150 | -0.090 | -7.3% | $1.250 | $1.277 | $1.130 | 313,800 | |
| $1.240 | -0.010 | -0.8% | $1.250 | $1.310 | $1.210 | 332,600 | |
| $1.250 | -0.030 | -2.3% | $1.290 | $1.320 | $1.200 | 232,700 | |
| $1.280 | -0.050 | -3.8% | $1.320 | $1.420 | $1.260 | 254,100 | |
| $1.330 | +0.060 | +4.7% | $1.270 | $1.370 | $1.190 | 351,300 | |
| $1.270 | +0.210 | +19.8% | $1.140 | $1.280 | $1.070 | 656,600 | |
| $1.060 | -0.260 | -19.7% | $1.300 | $1.330 | $0.930 | 609,400 | |
| $1.320 | -0.250 | -15.9% | $1.590 | $1.610 | $1.255 | 412,100 | |
| $1.570 | -0.040 | -2.5% | $1.620 | $1.730 | $1.570 | 125,400 | |
| $1.610 | -0.020 | -1.2% | $1.650 | $1.660 | $1.570 | 186,100 | |
| $1.630 | +0.010 | +0.6% | $1.630 | $1.658 | $1.590 | 121,600 | |
| $1.620 | -0.110 | -6.4% | $1.720 | $1.743 | $1.610 | 193,100 | |
| $1.730 | -0.030 | -1.7% | $1.740 | $1.805 | $1.730 | 126,700 | |
| $1.760 | -0.070 | -3.8% | $1.830 | $1.836 | $1.735 | 112,200 | |
| $1.830 | -0.040 | -2.1% | $1.890 | $2.000 | $1.810 | 170,100 | |
| $1.870 | +0.035 | +1.9% | $1.830 | $1.940 | $1.830 | 115,400 | |
| $1.835 | -0.015 | -0.8% | $1.830 | $1.900 | $1.810 | 77,500 | |
| $1.850 | -0.090 | -4.6% | $1.920 | $1.940 | $1.850 | 95,000 | |
| $1.940 | +0.030 | +1.6% | $1.910 | $1.959 | $1.870 | 164,100 | |
| $1.910 | +0.060 | +3.2% | $1.850 | $1.920 | $1.810 | 73,300 | |
| $1.850 | -0.030 | -1.6% | $1.890 | $1.910 | $1.840 | 98,500 | |
| $1.880 | +0.135 | +7.7% | $1.750 | $1.880 | $1.750 | 107,600 | |
| $1.745 | -0.055 | -3.1% | $1.810 | $1.840 | $1.745 | 96,000 | |
| $1.800 | -0.020 | -1.1% | $1.820 | $1.840 | $1.755 | 117,400 | |
| $1.820 | +0.020 | +1.1% | $1.800 | $1.919 | $1.780 | 337,300 | |
| $1.800 | +0.020 | +1.1% | $1.790 | $1.840 | $1.780 | 70,900 | |
| $1.780 | -0.040 | -2.2% | $1.820 | $1.830 | $1.760 | 87,500 | |
| $1.820 | +0.040 | +2.2% | $1.790 | $1.890 | $1.785 | 77,100 | |
| $1.780 | -0.080 | -4.3% | $1.870 | $1.870 | $1.770 | 63,400 | |
| $1.860 | +0.030 | +1.6% | $1.830 | $1.930 | $1.820 | 166,800 | |
| $1.830 | -0.050 | -2.7% | $1.870 | $1.890 | $1.820 | 126,100 | |
| $1.880 | -0.020 | -1.1% | $1.990 | $2.007 | $1.850 | 201,900 | |
| $1.900 | +0.040 | +2.2% | $1.890 | $1.910 | $1.810 | 100,500 | |
| $1.860 | -0.040 | -2.1% | $1.940 | $1.950 | $1.790 | 213,600 | |
| $1.900 | +0.130 | +7.3% | $1.810 | $2.040 | $1.810 | 355,700 | |
| $1.770 | 0.000 | 0.0% | $1.800 | $1.800 | $1.730 | 130,200 | |
| $1.770 | +0.010 | +0.6% | $1.800 | $1.820 | $1.750 | 98,700 | |
| $1.760 | 0.000 | 0.0% | $1.760 | $1.760 | $1.760 | 183,700 | |
| $1.760 | -0.110 | -5.9% | $1.870 | $1.880 | $1.700 | 390,000 | |
| $1.870 | +0.020 | +1.1% | $1.870 | $1.942 | $1.850 | 103,700 | |
| $1.850 | -0.150 | -7.5% | $2.020 | $2.020 | $1.800 | 519,900 | |
| $2.000 | -0.030 | -1.5% | $1.920 | $2.040 | $1.860 | 335,400 | |
| $2.030 | +0.010 | +0.5% | $2.030 | $2.059 | $2.000 | 393,500 | |
| $2.020 | -0.080 | -3.8% | $2.090 | $2.090 | $1.990 | 216,200 | |
| $2.100 | 0.000 | 0.0% | $2.080 | $2.130 | $2.000 | 185,400 | |
| $2.100 | -0.040 | -1.9% | $2.120 | $2.190 | $2.000 | 331,200 |
- Ticker
- gettex:69C
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- gettex
- Currency
- EUR
What changed lately
Latest news release · Oct 14, 2026
Tvardi Therapeutics to Participate in Chardan’s 10th Annual Healthcare Conference
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 63 slides
Calls
Replays
Cara Therapeutics, Inc. (CARA) Q4 2023 Earnings Call
Mon, Mar 04, 2024 · 4:30 PM ET
Watch TranscriptCara Therapeutics, Inc. (CARA) Q3 2023 Earnings Call
Mon, Nov 13, 2023 · 4:30 PM ET
Watch TranscriptCara Therapeutics, Inc. (CARA) Q2 2023 Earnings Call
Mon, Aug 07, 2023 · 4:30 PM ET
Watch Transcript
Latest news
Tvardi Therapeutics to Participate in Chardan’s 10th Annual Healthcare Conference
Oct 14, 2026
Closed $1.00 (-3.8%) on Oct 14, 2026
Tvardi Therapeutics Announces Second Quarter 2026 Results and Provides Business Update
Aug 14, 2026
Closed $1.90 (+7.3%) on Aug 14, 2026
Tvardi Therapeutics to Host KOL Webinar on the Clinical Potential of TTI-109 in Ulcerative Colitis (UC) and the Evolving Treatment Landscape, on August 19, 2026
Aug 12, 2026
Closed $1.77 (+0.6%) on Aug 12, 2026
Tvardi Therapeutics Selects Ulcerative Colitis as Initial Indication for TTI-109
Jul 30, 2026
Closed $2.10 (-1.9%) on Jul 30, 2026
Tvardi Therapeutics’ TTI-109 Phase 1 Study Confirms Prodrug Design, Improved Tolerability and Pharmacodynamic Evidence of STAT3 Target Engagement
Jul 7, 2026
Closed $3.10 (+54.2%) on Jul 7, 2026
Tvardi Therapeutics to Participate in Upcoming Investor Events
May 21, 2026
Closed $3.59 (-6.8%) on May 21, 2026
Tvardi Therapeutics Announces First Quarter 2026 Results and Provides Business Update
May 8, 2026
Closed $4.18 (-0.7%) on May 8, 2026
Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium
Apr 2, 2026
Closed $3.02 (+0.7%) on Apr 2, 2026
Tvardi Therapeutics Announces Fourth Quarter and Full-Year 2025 Results and Provides Business Update
Mar 31, 2026
Closed $3.18 (-0.6%) on Mar 31, 2026
Tvardi Therapeutics to Participate in Upcoming Investor Conferences
Feb 12, 2026
Closed $3.72 (-1.6%) on Feb 12, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 63 slides · September 2026
Technical Presentation (August 2026)
Technical · 38 slides · Aug 19, 2026
Investor Presentation (July 2026)
Investor deck · 63 slides · Jul 30, 2026
Investor Presentation (July 2026)
Investor deck · 56 slides · Jul 7, 2026
Tvardi Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 15 in the last 12 months · 100 in all · newest Oct 14, 2026 · oldest 2021
- Calls
- 14 calls with a replay · 14 with a transcript · latest Mar 4, 2024
- Decks
- 11 decks · latest September 2026
Where Tvardi Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:TVRD · Home listing | NASDAQ | United States | USD |
| Lang & Schwarz:A414VY | Lang & Schwarz | Germany | EUR |
| LS Exchange:A414VY | LS Exchange | Germany | EUR |
| Frankfurt:69C | Frankfurt | Germany | EUR |
| gettex:69C · This page | gettex | Germany | EUR |
| Tradegate:69C | Tradegate | Germany | EUR |
| Stuttgart:69C0 | Stuttgart | Germany | EUR |
| LSE:0HTC | LSE | United Kingdom | USD |
| BOATS:TVRD | BOATS | United States | USD |
| BX Swiss:TVRD | BX Swiss | Switzerland | CHF |
| Munich:69C | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about Tvardi Therapeutics, Inc.